UniProtKB/SwissProt variant VAR

Variant information

Variant position:

435

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Methionine (M) to Threonine (T) at position 435 (M435T, p.Met435Thr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (M) to medium size and polar (T)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In CMH1.

Any additional useful information about the variant.

Sequence information

Variant position:

435

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1935

The length of the canonical sequence.

Location on the sequence:

QNVQQVIYATGALAKAVYER M FNWMVTRINATLETKQPRQY

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QNVQQVIYATGALAKAVYERMFNWMVTRINATLETKQPRQY

                              QNVQQVAYATGALAKAVYEKMFNWMVTRINATLETKQPRQY

Mouse                         QNVQQVSYAIGALAKSVYEKMFNWMVTRINATLETKQPRQY

Rat                           QNVQQVAYAIGALAKSVYEKMFNWMVTRINATLETKQPRQY

Pig                           QNVQQVMYATGALAKAVYEKMFNWMVTRINTTLETKQPRQY

Bovine                        QNVQQVVYAKGALAKAVYERMFNWMVTRINATLETKQPRQY

Horse                         QNVQQVAYAKGALAKAVYERMFNWMVARINATLETKQPRQY

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1935	Myosin-7
Domain	85 – 778	Myosin motor
Helix	417 – 447

Literature citations

Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
Yu B.; Sawyer N.A.; Caramins M.; Yuan Z.G.; Saunderson R.B.; Pamphlett R.; Richmond D.R.; Jeremy R.W.; Trent R.J.;
J. Clin. Pathol. 58:479-485(2005)
Cited for: VARIANTS CMH1 VAL-227; GLY-328; GLU-351; GLN-403; TRP-403; ILE-411; THR-435; CYS-453; HIS-453; MET-606; CYS-663; GLN-719; TRP-719; HIS-787; GLY-894; VAL-908 AND LYS-927; VARIANT CYS-1519;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12883: Variant p.Met435Thr